fluorodeoxyglucose f18 has been researched along with aripiprazole in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartenstein, P; Fellgiebel, A; Hiemke, C; Müller, MJ; Schreckenberger, M | 1 |
| Howes, OD; Jang, IJ; Jeong, JM; Kapur, S; Kim, BH; Kim, E; Kim, JW; Kwon, JS; Lee, JS; Shin, SG; Turkheimer, FE | 1 |
| Bleich, S; Frieling, H; Hilfiker-Kleiner, D; Kahl, KG; Kotsiari, A; Scherr, M; Stapel, B | 1 |
1 trial(s) available for fluorodeoxyglucose f18 and aripiprazole
| Article | Year |
|---|---|
The relationship between antipsychotic D2 occupancy and change in frontal metabolism and working memory : A dual [(11)C]raclopride and [(18) F]FDG imaging study with aripiprazole.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Carbon Radioisotopes; Cognition; Corpus Striatum; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Male; Memory, Short-Term; Piperazines; Positron-Emission Tomography; Quinolones; Raclopride; Reaction Time; Receptors, Dopamine D2; Single-Blind Method; Young Adult | 2013 |
2 other study(ies) available for fluorodeoxyglucose f18 and aripiprazole
| Article | Year |
|---|---|
Clinical improvement in a case of frontotemporal dementia under aripiprazole treatment corresponds to partial recovery of disturbed frontal glucose metabolism.
Topics: Aged; Antipsychotic Agents; Aripiprazole; Blood Glucose; Dementia; Fluorodeoxyglucose F18; Follow-Up Studies; Frontal Lobe; Humans; Male; Mental Status Schedule; Piperazines; Positron-Emission Tomography; Psychiatric Status Rating Scales; Quinolones; Treatment Outcome | 2007 |
Olanzapine and aripiprazole differentially affect glucose uptake and energy metabolism in human mononuclear blood cells.
Topics: AMP-Activated Protein Kinase Kinases; Antigens, CD; Antipsychotic Agents; Aripiprazole; Benzodiazepines; DNA Methylation; Dose-Response Relationship, Drug; Excitatory Amino Acid Transporter 2; Flow Cytometry; Fluorodeoxyglucose F18; Gene Expression Regulation; Glucose; Glucose Transporter Type 3; Glutamate Plasma Membrane Transport Proteins; Humans; Ketone Oxidoreductases; Leukocytes, Mononuclear; Olanzapine; Protein Kinases; RNA, Messenger; RNA, Ribosomal, 18S; Statistics, Nonparametric | 2017 |